| Dr Eva Samella Salvacion Salcedo, MD | |
|
8208 Gulf Freeway Suite 101, Houston, TX 77017-4507 | |
| (713) 649-0870 | |
| (713) 649-7130 |
| Full Name | Dr Eva Samella Salvacion Salcedo |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 8208 Gulf Freeway Suite 101, Houston, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194958017 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | N4057 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Memorial Hermann - Texas Medical Center | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company's global manufacturing footprint and establishes local production capabilities to meet increased customer demand in China and other Asia-Pacific markets.
Growth hormone is used to treat children's growth disorders and has been used by some sports men and women to promote muscle growth and regeneration. This is because it coordinates skeletal muscle development, nutrient uptake, and nutrient utilization. It is not clear, however, which of these effects are direct and which are indirectly mediated via growth hormone induction of the protein IGF-1.
Since the enactment of the National Cancer Act in 1971, the U.S. has spent hundreds of billions of dollars in cancer research and treatment. And yet, the cancer mortality rate-the historic benchmark of progress-has only declined modestly while the mortality rates of other leading causes of death have declined substantially. This difference has led many to question whether we've made progress in the 'War on Cancer'. The answer is definitively yes according to Norris Cotton Cancer Center research published Monday in the Journal of Clinical Oncology.
For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival.
› Verified 9 days ago
| Entity Name | Memorial Hermann Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company's global manufacturing footprint and establishes local production capabilities to meet increased customer demand in China and other Asia-Pacific markets.
Growth hormone is used to treat children's growth disorders and has been used by some sports men and women to promote muscle growth and regeneration. This is because it coordinates skeletal muscle development, nutrient uptake, and nutrient utilization. It is not clear, however, which of these effects are direct and which are indirectly mediated via growth hormone induction of the protein IGF-1.
Since the enactment of the National Cancer Act in 1971, the U.S. has spent hundreds of billions of dollars in cancer research and treatment. And yet, the cancer mortality rate-the historic benchmark of progress-has only declined modestly while the mortality rates of other leading causes of death have declined substantially. This difference has led many to question whether we've made progress in the 'War on Cancer'. The answer is definitively yes according to Norris Cotton Cancer Center research published Monday in the Journal of Clinical Oncology.
For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eva Samella Salvacion Salcedo, MD 8208 Gulf Freeway Suite 101, Houston, TX 77017-4507 Ph: (713) 649-0870 | Dr Eva Samella Salvacion Salcedo, MD 8208 Gulf Freeway Suite 101, Houston, TX 77017-4507 Ph: (713) 649-0870 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company's global manufacturing footprint and establishes local production capabilities to meet increased customer demand in China and other Asia-Pacific markets.
Growth hormone is used to treat children's growth disorders and has been used by some sports men and women to promote muscle growth and regeneration. This is because it coordinates skeletal muscle development, nutrient uptake, and nutrient utilization. It is not clear, however, which of these effects are direct and which are indirectly mediated via growth hormone induction of the protein IGF-1.
Since the enactment of the National Cancer Act in 1971, the U.S. has spent hundreds of billions of dollars in cancer research and treatment. And yet, the cancer mortality rate-the historic benchmark of progress-has only declined modestly while the mortality rates of other leading causes of death have declined substantially. This difference has led many to question whether we've made progress in the 'War on Cancer'. The answer is definitively yes according to Norris Cotton Cancer Center research published Monday in the Journal of Clinical Oncology.
For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival.
› Verified 9 days ago
Dr. Jeanette Ferrer, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6565 Fannin St., Main 577, Houston, TX 77030 Phone: 713-441-0428 | |
Dr. Bhavik Kumar, MD, MPH Family Medicine Medicare: Medicare Enrolled Practice Location: 4600 Gulf Fwy, Houston, TX 77023 Phone: 713-522-3976 Fax: 404-494-7435 | |
Nneka Okafor, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3701 Kirby Dr Ste 600, Houston, TX 77098 Phone: 713-798-8072 | |
Dr. Rolando R Maldonado I, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 548 Waugh Dr, Houston, TX 77019 Phone: 713-933-0501 | |
Scott H Hung, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10950 Resource Pkwy, Suite A, Houston, TX 77089 Phone: 281-484-5587 Fax: 281-506-1013 | |
Michael E. Buxbaum, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Weslayan St Ste 350, Houston, TX 77027 Phone: 713-533-1700 Fax: 713-533-1708 | |
Diana Atwal, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6630 De Moss Dr, Houston, TX 77074 Phone: 713-272-2600 Fax: 713-272-5589 |